The Latest in Hepatitis

Infectious Disease Practitioner

HCV treatment program achieves 97% SVR among homeless

April 10, 2017

Hepatitis

Infectious Disease Practitioner

FDA approves Sovaldi, Harvoni for HCV in ages 12-plus

April 7, 2017

Infectious Disease Practitioner

Hepatitis B, C appear to raise Parkinson’s risk

April 4, 2017

Hepatitis

Infectious Disease Practitioner

Eliminating hepatitis in the United States: A road map

April 3, 2017

Hepatitis

Infectious Disease Practitioner

Elbasvir, grazoprevir beat HCV despite compensated cirrhosis

April 3, 2017

Hepatitis

Infectious Disease Practitioner

Doubt expressed about potential of any single regimen to treat all hep C

March 30, 2017

Hepatitis

Infectious Disease Practitioner

Of six milestones, only two left on route to hep B cure

March 30, 2017

Hepatitis

Infectious Disease Practitioner

Hepatitis Outlook: Late February 2017

March 21, 2017

Hepatitis

Infectious Disease Practitioner

Antiviral medication successful for treating HCV in hepatocellular carcinoma

March 16, 2017

Hepatitis

Infectious Disease Practitioner

HCV ‘cure’ within the VA appears likely

March 16, 2017

Hepatitis

Infectious Disease Practitioner

Infant hepatitis B vaccine protection lingers into adolescence

March 15, 2017

Infectious Disease Practitioner

HCV testing stagnant among baby boomers

March 10, 2017

Hepatitis

Infectious Disease Practitioner

Hepatitis outlook: early February 2017

March 2, 2017

Hepatitis

Infectious Disease Practitioner

VIDEO: Bacterial DNA predicted infections associated with prednisolone in severe alcoholic hepatitis

February 25, 2017

Infectious Disease Practitioner

Unrestricted DAA access halved Dutch HCV incidence in HIV

February 23, 2017